Does Debulking Surgery Improve Survival in Biologically Aggressive Ovarian Carcinoma?
- 30 November 1997
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 67 (2) , 208-214
- https://doi.org/10.1006/gyno.1997.4839
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Neoadjuvant chemotherapy for advanced ovarian cancerInternational Journal of Gynecologic Cancer, 1996
- The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian CancerNew England Journal of Medicine, 1995
- The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian CancerGynecologic Oncology, 1995
- The Influence of Tumor Grade, Distribution, and Extent of Carcinomatosis in Minimal Residual Stage III Epithelial Ovarian Cancer after Optimal Primary Cytoreductive SurgeryGynecologic Oncology, 1994
- Neoadjuvant Chemotherapy for Advanced Ovarian CancerGynecologic Oncology, 1994
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- Surgery for Ovarian CancerHematology/Oncology Clinics of North America, 1992
- Neoadjuvant chemotherapy in stage X ovarian carcinomaGynecologic Oncology, 1990
- Stage III epithelial ovarian cancer: The role of maximal surgical reductionGynecologic Oncology, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958